| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |